Gene Symbol | Gene ID | Gene Info |
---|---|---|
Spic
|
ENSMUSG00000004359.10 | Spi-C transcription factor (Spi-1/PU.1 related) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr10_88682299_88682450 | Spic | 649 | 0.521549 | 0.58 | 1.0e-06 | Click! |
chr10_88682740_88682891 | Spic | 208 | 0.871636 | 0.54 | 7.0e-06 | Click! |
chr10_88682499_88682650 | Spic | 449 | 0.673422 | 0.38 | 2.6e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_84180639_84182724 | 18.32 |
Gm36279 |
predicted gene, 36279 |
4075 |
0.18 |
chr5_64810297_64813272 | 15.32 |
Klf3 |
Kruppel-like factor 3 (basic) |
555 |
0.71 |
chr7_45238275_45239242 | 14.13 |
Cd37 |
CD37 antigen |
38 |
0.92 |
chr17_48300015_48301474 | 13.65 |
Treml2 |
triggering receptor expressed on myeloid cells-like 2 |
358 |
0.8 |
chr6_113690658_113691420 | 13.59 |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
294 |
0.72 |
chr6_116352148_116352610 | 13.14 |
Marchf8 |
membrane associated ring-CH-type finger 8 |
1446 |
0.3 |
chr11_87756102_87757558 | 13.14 |
Mir142 |
microRNA 142 |
34 |
0.59 |
chr7_103827140_103827838 | 12.80 |
Hbb-bs |
hemoglobin, beta adult s chain |
236 |
0.77 |
chr7_103813135_103813893 | 12.29 |
Hbb-bt |
hemoglobin, beta adult t chain |
482 |
0.54 |
chr8_84701273_84703379 | 12.13 |
Lyl1 |
lymphoblastomic leukemia 1 |
545 |
0.59 |
chr18_54424022_54424266 | 11.65 |
Redrum |
Redrum, erythroid developmental long intergenic non-protein coding transcript |
1849 |
0.43 |
chr6_31612888_31614126 | 11.52 |
Gm43154 |
predicted gene 43154 |
8218 |
0.19 |
chr6_146222065_146222293 | 11.17 |
Itpr2 |
inositol 1,4,5-triphosphate receptor 2 |
5364 |
0.27 |
chr7_127296174_127297414 | 10.87 |
Itgal |
integrin alpha L |
384 |
0.68 |
chr9_65575682_65576108 | 10.85 |
Plekho2 |
pleckstrin homology domain containing, family O member 2 |
1205 |
0.39 |
chr6_108306863_108307717 | 10.76 |
Itpr1 |
inositol 1,4,5-trisphosphate receptor 1 |
48964 |
0.16 |
chr6_145302951_145304100 | 10.49 |
2010013B24Rik |
RIKEN cDNA 2010013B24 gene |
373 |
0.66 |
chr10_21377273_21377859 | 10.32 |
Aldh8a1 |
aldehyde dehydrogenase 8 family, member A1 |
219 |
0.91 |
chr5_117133717_117134877 | 10.17 |
Taok3 |
TAO kinase 3 |
656 |
0.62 |
chr7_44479611_44481283 | 9.98 |
5430431A17Rik |
RIKEN cDNA 5430431A17 gene |
4070 |
0.08 |
chr3_135608020_135608578 | 9.91 |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
29 |
0.98 |
chr19_32179674_32180543 | 9.71 |
Sgms1 |
sphingomyelin synthase 1 |
16320 |
0.21 |
chr7_132776252_132776889 | 9.64 |
Fam53b |
family with sequence similarity 53, member B |
346 |
0.89 |
chr7_127767459_127768302 | 9.36 |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
1935 |
0.14 |
chrX_8271051_8272966 | 9.11 |
Slc38a5 |
solute carrier family 38, member 5 |
366 |
0.82 |
chr9_107975554_107976970 | 8.92 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
46 |
0.91 |
chr8_88300415_88300996 | 8.90 |
Adcy7 |
adenylate cyclase 7 |
326 |
0.89 |
chr1_173332160_173333204 | 8.79 |
Ackr1 |
atypical chemokine receptor 1 (Duffy blood group) |
820 |
0.54 |
chr2_79256898_79257323 | 8.77 |
Itga4 |
integrin alpha 4 |
1163 |
0.57 |
chr13_45512026_45513101 | 8.73 |
Gmpr |
guanosine monophosphate reductase |
1277 |
0.51 |
chr13_59820826_59821264 | 8.67 |
Tut7 |
terminal uridylyl transferase 7 |
1543 |
0.23 |
chr8_122546551_122549259 | 8.64 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
3424 |
0.12 |
chr7_103812275_103812465 | 8.37 |
Hbb-bt |
hemoglobin, beta adult t chain |
1626 |
0.15 |
chr11_48869797_48870455 | 8.30 |
Irgm1 |
immunity-related GTPase family M member 1 |
1248 |
0.29 |
chr12_33313990_33315181 | 8.22 |
Atxn7l1 |
ataxin 7-like 1 |
185 |
0.95 |
chr6_90619034_90619910 | 8.20 |
Slc41a3 |
solute carrier family 41, member 3 |
325 |
0.85 |
chr19_5691875_5693863 | 8.17 |
Map3k11 |
mitogen-activated protein kinase kinase kinase 11 |
26 |
0.92 |
chr15_102460089_102460942 | 8.12 |
Prr13 |
proline rich 13 |
432 |
0.68 |
chr2_93461586_93463194 | 8.11 |
Cd82 |
CD82 antigen |
4 |
0.98 |
chr6_136854322_136855143 | 8.11 |
Art4 |
ADP-ribosyltransferase 4 |
3001 |
0.12 |
chr19_10015065_10016667 | 8.10 |
Rab3il1 |
RAB3A interacting protein (rabin3)-like 1 |
822 |
0.48 |
chr10_80535020_80535804 | 8.09 |
Atp8b3 |
ATPase, class I, type 8B, member 3 |
3678 |
0.11 |
chr14_70706940_70707491 | 8.09 |
Xpo7 |
exportin 7 |
820 |
0.57 |
chr19_7018033_7019009 | 7.98 |
Fermt3 |
fermitin family member 3 |
824 |
0.38 |
chr10_80570596_80572042 | 7.94 |
Klf16 |
Kruppel-like factor 16 |
6002 |
0.08 |
chr1_75215644_75216192 | 7.86 |
Tuba4a |
tubulin, alpha 4A |
1496 |
0.15 |
chr5_129006398_129007001 | 7.85 |
Stx2 |
syntaxin 2 |
1724 |
0.37 |
chr15_103453834_103454841 | 7.81 |
Nckap1l |
NCK associated protein 1 like |
510 |
0.7 |
chr18_60500054_60500289 | 7.81 |
Smim3 |
small integral membrane protein 3 |
1405 |
0.38 |
chr12_32111429_32112319 | 7.76 |
5430401H09Rik |
RIKEN cDNA 5430401H09 gene |
11828 |
0.18 |
chr11_82845042_82846306 | 7.75 |
Rffl |
ring finger and FYVE like domain containing protein |
418 |
0.75 |
chr1_87650650_87651222 | 7.73 |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
25303 |
0.15 |
chr3_57425771_57426240 | 7.71 |
Tm4sf4 |
transmembrane 4 superfamily member 4 |
691 |
0.74 |
chr7_75586786_75587711 | 7.66 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
22791 |
0.17 |
chr15_86051078_86051312 | 7.66 |
Gramd4 |
GRAM domain containing 4 |
6500 |
0.19 |
chr2_167588684_167589456 | 7.49 |
Gm11475 |
predicted gene 11475 |
2325 |
0.19 |
chr11_83285353_83286025 | 7.47 |
Slfn14 |
schlafen 14 |
1037 |
0.31 |
chr4_46040988_46042013 | 7.30 |
Tmod1 |
tropomodulin 1 |
2291 |
0.3 |
chr19_5660333_5662014 | 7.20 |
Sipa1 |
signal-induced proliferation associated gene 1 |
462 |
0.59 |
chr4_98436713_98437393 | 7.16 |
Patj |
PATJ, crumbs cell polarity complex component |
110 |
0.97 |
chr14_41006333_41006867 | 7.10 |
Prxl2a |
peroxiredoxin like 2A |
320 |
0.88 |
chr1_40430303_40430529 | 7.06 |
Il1rl1 |
interleukin 1 receptor-like 1 |
846 |
0.63 |
chr11_78169162_78169671 | 7.04 |
Nek8 |
NIMA (never in mitosis gene a)-related expressed kinase 8 |
412 |
0.6 |
chr1_9799032_9799183 | 6.96 |
Sgk3 |
serum/glucocorticoid regulated kinase 3 |
899 |
0.47 |
chr13_107100937_107101851 | 6.95 |
Gm31452 |
predicted gene, 31452 |
37699 |
0.14 |
chr11_96942052_96942604 | 6.93 |
Pnpo |
pyridoxine 5'-phosphate oxidase |
1451 |
0.2 |
chr4_32170638_32171072 | 6.85 |
Gm11928 |
predicted gene 11928 |
21069 |
0.18 |
chr5_90492212_90493160 | 6.70 |
Afp |
alpha fetoprotein |
1448 |
0.33 |
chr9_58248942_58249216 | 6.68 |
Pml |
promyelocytic leukemia |
544 |
0.66 |
chr5_149067537_149068405 | 6.63 |
Hmgb1 |
high mobility group box 1 |
14458 |
0.11 |
chr7_28982862_28983600 | 6.62 |
Map4k1 |
mitogen-activated protein kinase kinase kinase kinase 1 |
370 |
0.72 |
chr4_43559728_43560658 | 6.60 |
Tln1 |
talin 1 |
1733 |
0.15 |
chr9_58246028_58246254 | 6.58 |
Pml |
promyelocytic leukemia |
3482 |
0.15 |
chr15_76242501_76243437 | 6.33 |
Parp10 |
poly (ADP-ribose) polymerase family, member 10 |
451 |
0.59 |
chr1_9545358_9547473 | 6.29 |
Rrs1 |
ribosome biogenesis regulator 1 |
1007 |
0.38 |
chr19_4058692_4059651 | 6.28 |
Gstp3 |
glutathione S-transferase pi 3 |
124 |
0.88 |
chr6_29696862_29697373 | 6.26 |
Tspan33 |
tetraspanin 33 |
2883 |
0.24 |
chr16_32163155_32163697 | 6.20 |
Nrros |
negative regulator of reactive oxygen species |
2031 |
0.22 |
chr18_75502739_75503903 | 6.07 |
Gm10532 |
predicted gene 10532 |
11324 |
0.26 |
chr4_103120815_103121384 | 6.06 |
Mier1 |
MEIR1 treanscription regulator |
1689 |
0.32 |
chr3_137980299_137981827 | 6.04 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
467 |
0.74 |
chr7_120173917_120175138 | 6.04 |
Anks4b |
ankyrin repeat and sterile alpha motif domain containing 4B |
669 |
0.61 |
chr1_132387629_132389330 | 6.02 |
Tmcc2 |
transmembrane and coiled-coil domains 2 |
1839 |
0.25 |
chr10_95677335_95678276 | 6.01 |
Anapc15-ps |
anaphase promoting complex C subunit 15, pseudogene |
4354 |
0.14 |
chr18_56926778_56927036 | 5.99 |
Marchf3 |
membrane associated ring-CH-type finger 3 |
1359 |
0.45 |
chr16_76365731_76366199 | 5.87 |
Nrip1 |
nuclear receptor interacting protein 1 |
7072 |
0.21 |
chr2_36230119_36231737 | 5.85 |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
372 |
0.79 |
chr10_67002257_67005140 | 5.81 |
Gm31763 |
predicted gene, 31763 |
1322 |
0.45 |
chr5_64487848_64488419 | 5.78 |
C030018K13Rik |
RIKEN cDNA C030018K13 gene |
11098 |
0.13 |
chr8_47947601_47948329 | 5.77 |
Wwc2 |
WW, C2 and coiled-coil domain containing 2 |
42586 |
0.12 |
chr3_27316895_27317871 | 5.77 |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
322 |
0.89 |
chr16_49839981_49840391 | 5.76 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
15180 |
0.25 |
chr12_111943340_111944555 | 5.75 |
5033406O09Rik |
RIKEN cDNA 5033406O09 gene |
199 |
0.89 |
chr6_86665747_86666130 | 5.75 |
Gm44292 |
predicted gene, 44292 |
387 |
0.74 |
chr6_91115315_91115581 | 5.73 |
Nup210 |
nucleoporin 210 |
1348 |
0.37 |
chr15_97342720_97342894 | 5.68 |
Pced1b |
PC-esterase domain containing 1B |
18395 |
0.22 |
chr10_81060304_81060538 | 5.66 |
Sgta |
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha |
240 |
0.82 |
chr14_77904099_77904332 | 5.65 |
Epsti1 |
epithelial stromal interaction 1 (breast) |
24 |
0.98 |
chr16_49854254_49854405 | 5.64 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
1037 |
0.65 |
chr4_135895417_135895899 | 5.63 |
Cnr2 |
cannabinoid receptor 2 (macrophage) |
264 |
0.84 |
chr2_80037645_80038971 | 5.63 |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
721 |
0.79 |
chr13_24501559_24502461 | 5.59 |
Ripor2 |
RHO family interacting cell polarization regulator 2 |
485 |
0.79 |
chr1_176836732_176837286 | 5.59 |
Gm38158 |
predicted gene, 38158 |
1285 |
0.31 |
chr9_113941322_113941799 | 5.58 |
Ubp1 |
upstream binding protein 1 |
9906 |
0.2 |
chrX_74426313_74426689 | 5.57 |
Ikbkg |
inhibitor of kappaB kinase gamma |
1401 |
0.23 |
chr19_53257195_53257790 | 5.56 |
1700001K23Rik |
RIKEN cDNA 1700001K23 gene |
2272 |
0.25 |
chr1_181852456_181853806 | 5.55 |
Gm5533 |
predicted gene 5533 |
58 |
0.96 |
chr4_41388141_41388689 | 5.55 |
Kif24 |
kinesin family member 24 |
16371 |
0.12 |
chr2_156729964_156731107 | 5.54 |
Dlgap4 |
DLG associated protein 4 |
9043 |
0.13 |
chr7_24373502_24374343 | 5.54 |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
3584 |
0.11 |
chr4_71291873_71292024 | 5.54 |
Gm11229 |
predicted gene 11229 |
6006 |
0.31 |
chr12_69374532_69375203 | 5.51 |
Gm9887 |
predicted gene 9887 |
2399 |
0.15 |
chr3_83026692_83027527 | 5.51 |
Fga |
fibrinogen alpha chain |
894 |
0.5 |
chr2_91183636_91184223 | 5.50 |
Madd |
MAP-kinase activating death domain |
92 |
0.94 |
chr19_6856906_6858230 | 5.46 |
Ccdc88b |
coiled-coil domain containing 88B |
643 |
0.54 |
chr11_106313721_106314559 | 5.46 |
Cd79b |
CD79B antigen |
389 |
0.75 |
chr19_29707870_29708563 | 5.45 |
Mlana |
melan-A |
10282 |
0.19 |
chr1_170975825_170976111 | 5.45 |
Fcgr2b |
Fc receptor, IgG, low affinity IIb |
159 |
0.9 |
chr13_20150477_20151150 | 5.43 |
Elmo1 |
engulfment and cell motility 1 |
34394 |
0.22 |
chr5_149245583_149246503 | 5.42 |
Gm29264 |
predicted gene 29264 |
1639 |
0.19 |
chr6_31125380_31126701 | 5.42 |
5330406M23Rik |
RIKEN cDNA 5330406M23 gene |
15120 |
0.11 |
chr9_72409146_72409876 | 5.39 |
Gm27255 |
predicted gene 27255 |
243 |
0.57 |
chr3_60504423_60505028 | 5.39 |
Mbnl1 |
muscleblind like splicing factor 1 |
3447 |
0.29 |
chr11_34783325_34783929 | 5.38 |
Dock2 |
dedicator of cyto-kinesis 2 |
256 |
0.94 |
chr15_78325871_78326729 | 5.36 |
Csf2rb |
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
244 |
0.88 |
chr2_61514257_61514677 | 5.36 |
Gm22338 |
predicted gene, 22338 |
21701 |
0.24 |
chr18_25097263_25097927 | 5.35 |
Fhod3 |
formin homology 2 domain containing 3 |
26766 |
0.22 |
chr17_71215351_71215502 | 5.33 |
Lpin2 |
lipin 2 |
10750 |
0.16 |
chr2_166702788_166703193 | 5.31 |
Prex1 |
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 |
604 |
0.76 |
chr8_117298110_117298642 | 5.29 |
Cmip |
c-Maf inducing protein |
41259 |
0.17 |
chr2_18821363_18822378 | 5.29 |
Carlr |
cardiac and apoptosis-related long non-coding RNA |
20052 |
0.17 |
chr19_17355077_17356896 | 5.28 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
681 |
0.75 |
chr11_45806324_45807052 | 5.27 |
F630206G17Rik |
RIKEN cDNA F630206G17 gene |
1399 |
0.35 |
chr7_27451486_27451637 | 5.26 |
Blvrb |
biliverdin reductase B (flavin reductase (NADPH)) |
857 |
0.4 |
chr10_81135061_81135250 | 5.24 |
Zbtb7a |
zinc finger and BTB domain containing 7a |
65 |
0.93 |
chr12_110977542_110977693 | 5.19 |
Ankrd9 |
ankyrin repeat domain 9 |
638 |
0.59 |
chr11_11691757_11691908 | 5.17 |
Gm12000 |
predicted gene 12000 |
4607 |
0.18 |
chr3_103859461_103860226 | 5.17 |
Ptpn22 |
protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
48 |
0.94 |
chr11_44528978_44529659 | 5.15 |
Rnf145 |
ring finger protein 145 |
9013 |
0.18 |
chr7_88482138_88482595 | 5.14 |
Gm15661 |
predicted gene 15661 |
33136 |
0.16 |
chr6_136940269_136941762 | 5.13 |
Arhgdib |
Rho, GDP dissociation inhibitor (GDI) beta |
488 |
0.73 |
chr8_123978308_123979538 | 5.11 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
4199 |
0.12 |
chr4_140701540_140702640 | 5.09 |
Rcc2 |
regulator of chromosome condensation 2 |
617 |
0.61 |
chr3_121260861_121261012 | 5.06 |
Tlcd4 |
TLC domain containing 4 |
2378 |
0.22 |
chr15_84325346_84325775 | 5.02 |
Parvg |
parvin, gamma |
559 |
0.69 |
chr7_99594627_99596228 | 5.01 |
Arrb1 |
arrestin, beta 1 |
804 |
0.48 |
chr9_123480120_123480887 | 4.98 |
Limd1 |
LIM domains containing 1 |
107 |
0.97 |
chr7_110773186_110773486 | 4.97 |
Ampd3 |
adenosine monophosphate deaminase 3 |
336 |
0.84 |
chr5_64505210_64506632 | 4.97 |
C030018K13Rik |
RIKEN cDNA C030018K13 gene |
28886 |
0.11 |
chr6_72389419_72390767 | 4.96 |
Vamp8 |
vesicle-associated membrane protein 8 |
182 |
0.89 |
chr11_83284443_83284738 | 4.93 |
Slfn14 |
schlafen 14 |
2136 |
0.15 |
chr11_101448217_101448875 | 4.93 |
Ifi35 |
interferon-induced protein 35 |
24 |
0.92 |
chr13_49308099_49309227 | 4.91 |
Fgd3 |
FYVE, RhoGEF and PH domain containing 3 |
577 |
0.76 |
chr10_60348829_60349797 | 4.91 |
Vsir |
V-set immunoregulatory receptor |
10 |
0.98 |
chr2_157026864_157027931 | 4.91 |
Soga1 |
suppressor of glucose, autophagy associated 1 |
75 |
0.96 |
chr2_75792456_75792823 | 4.90 |
Gm13657 |
predicted gene 13657 |
15451 |
0.13 |
chr7_75612178_75613652 | 4.88 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
631 |
0.75 |
chr9_44579315_44579766 | 4.87 |
Gm47230 |
predicted gene, 47230 |
68 |
0.93 |
chr3_88337516_88337967 | 4.87 |
Smg5 |
Smg-5 homolog, nonsense mediated mRNA decay factor (C. elegans) |
1376 |
0.17 |
chr4_156252393_156253403 | 4.85 |
Samd11 |
sterile alpha motif domain containing 11 |
503 |
0.6 |
chr4_83273839_83274082 | 4.85 |
Ttc39b |
tetratricopeptide repeat domain 39B |
5447 |
0.21 |
chr14_55061871_55064122 | 4.84 |
Gm20687 |
predicted gene 20687 |
7503 |
0.08 |
chr17_26956832_26957754 | 4.83 |
Syngap1 |
synaptic Ras GTPase activating protein 1 homolog (rat) |
533 |
0.53 |
chr8_123980288_123980565 | 4.82 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
2696 |
0.15 |
chr12_111442182_111444685 | 4.82 |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
771 |
0.51 |
chr18_69665931_69667348 | 4.81 |
Tcf4 |
transcription factor 4 |
9972 |
0.29 |
chr15_86181872_86183211 | 4.80 |
Gm15569 |
predicted gene 15569 |
3187 |
0.2 |
chr7_101322770_101322949 | 4.79 |
Stard10 |
START domain containing 10 |
888 |
0.41 |
chr2_167042371_167043481 | 4.77 |
Znfx1 |
zinc finger, NFX1-type containing 1 |
569 |
0.58 |
chr3_30765479_30765954 | 4.73 |
Samd7 |
sterile alpha motif domain containing 7 |
9494 |
0.14 |
chr10_62506072_62506873 | 4.72 |
Srgn |
serglycin |
1283 |
0.36 |
chr4_63152318_63152930 | 4.70 |
Ambp |
alpha 1 microglobulin/bikunin precursor |
1549 |
0.36 |
chr16_32613535_32613686 | 4.67 |
Tfrc |
transferrin receptor |
1622 |
0.3 |
chr7_102246806_102247734 | 4.66 |
Rhog |
ras homolog family member G |
2818 |
0.17 |
chr9_65578772_65580051 | 4.64 |
Plekho2 |
pleckstrin homology domain containing, family O member 2 |
377 |
0.82 |
chr5_51557597_51558038 | 4.64 |
Ppargc1a |
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
3895 |
0.25 |
chr15_78598877_78599408 | 4.64 |
Cyth4 |
cytohesin 4 |
1993 |
0.21 |
chr10_121473495_121473966 | 4.63 |
Rassf3 |
Ras association (RalGDS/AF-6) domain family member 3 |
2617 |
0.17 |
chr14_70207531_70208311 | 4.62 |
Gm49417 |
predicted gene, 49417 |
170 |
0.63 |
chr2_84735706_84738103 | 4.61 |
Ypel4 |
yippee like 4 |
2677 |
0.11 |
chr2_140778093_140778452 | 4.61 |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
106803 |
0.07 |
chr9_50533286_50533787 | 4.61 |
Gm47077 |
predicted gene, 47077 |
4769 |
0.11 |
chr19_4558659_4559358 | 4.60 |
Pcx |
pyruvate carboxylase |
198 |
0.92 |
chr16_34031777_34032155 | 4.57 |
Kalrn |
kalirin, RhoGEF kinase |
15472 |
0.19 |
chr2_58160498_58161190 | 4.57 |
Cytip |
cytohesin 1 interacting protein |
187 |
0.94 |
chr8_80497324_80498362 | 4.56 |
Gypa |
glycophorin A |
4062 |
0.27 |
chr7_128301638_128302100 | 4.55 |
BC017158 |
cDNA sequence BC017158 |
3699 |
0.12 |
chr6_55338294_55340060 | 4.55 |
Aqp1 |
aquaporin 1 |
2745 |
0.22 |
chr19_12573120_12574715 | 4.55 |
Fam111a |
family with sequence similarity 111, member A |
394 |
0.72 |
chr11_69946825_69947001 | 4.52 |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
1061 |
0.21 |
chr8_122700283_122700946 | 4.51 |
Cbfa2t3 |
CBFA2/RUNX1 translocation partner 3 |
1505 |
0.24 |
chr9_58246669_58247815 | 4.50 |
Pml |
promyelocytic leukemia |
2381 |
0.19 |
chr4_130251311_130251820 | 4.50 |
Serinc2 |
serine incorporator 2 |
23653 |
0.13 |
chr4_88550254_88550926 | 4.49 |
Ifna15 |
interferon alpha 15 |
7655 |
0.1 |
chr6_72544169_72544812 | 4.47 |
Capg |
capping protein (actin filament), gelsolin-like |
47 |
0.96 |
chr1_132416784_132416935 | 4.44 |
Dstyk |
dual serine/threonine and tyrosine protein kinase |
696 |
0.61 |
chr11_79279185_79279336 | 4.44 |
Gm44787 |
predicted gene 44787 |
5367 |
0.17 |
chr2_14229427_14230751 | 4.43 |
Mrc1 |
mannose receptor, C type 1 |
697 |
0.66 |
chr1_55028864_55029049 | 4.42 |
Sf3b1 |
splicing factor 3b, subunit 1 |
1475 |
0.31 |
chr17_34589250_34590501 | 4.42 |
Gpsm3 |
G-protein signalling modulator 3 (AGS3-like, C. elegans) |
69 |
0.89 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 14.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
3.5 | 14.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
3.3 | 10.0 | GO:0036394 | amylase secretion(GO:0036394) |
3.2 | 9.5 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
2.7 | 10.7 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
2.7 | 8.0 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
2.4 | 4.8 | GO:0032672 | regulation of interleukin-3 production(GO:0032672) |
2.3 | 6.9 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
2.1 | 14.9 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
2.1 | 6.3 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.1 | 6.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
2.1 | 6.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
2.0 | 10.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.9 | 5.8 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
1.9 | 7.7 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
1.7 | 5.2 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.7 | 5.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
1.7 | 8.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.7 | 8.6 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
1.7 | 6.9 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.7 | 3.4 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.7 | 3.4 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
1.7 | 3.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.7 | 3.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.6 | 4.9 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.6 | 4.7 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
1.6 | 4.7 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
1.6 | 6.2 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.6 | 7.8 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
1.5 | 4.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.5 | 6.0 | GO:0008228 | opsonization(GO:0008228) |
1.5 | 5.9 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
1.4 | 4.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.4 | 5.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
1.4 | 4.2 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.4 | 6.8 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.4 | 10.9 | GO:0032782 | bile acid secretion(GO:0032782) |
1.3 | 4.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.3 | 2.6 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
1.3 | 3.9 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
1.3 | 2.6 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.3 | 6.4 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
1.3 | 17.9 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.3 | 2.5 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
1.2 | 1.2 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
1.2 | 4.8 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.2 | 4.7 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
1.1 | 3.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.1 | 2.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.1 | 4.5 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
1.1 | 4.4 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.1 | 3.2 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
1.1 | 4.3 | GO:0032264 | IMP salvage(GO:0032264) |
1.1 | 2.1 | GO:0002432 | granuloma formation(GO:0002432) |
1.0 | 7.3 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.0 | 2.1 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
1.0 | 4.1 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
1.0 | 3.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.0 | 4.0 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
1.0 | 8.0 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
1.0 | 4.0 | GO:0003099 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
1.0 | 4.9 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.0 | 2.9 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
1.0 | 3.8 | GO:0070836 | caveola assembly(GO:0070836) |
0.9 | 4.7 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.9 | 3.8 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.9 | 4.7 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.9 | 1.9 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.9 | 0.9 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.9 | 3.7 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.9 | 4.6 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.9 | 4.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.9 | 2.7 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.9 | 4.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.9 | 2.7 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.9 | 1.8 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.9 | 4.3 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.9 | 6.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.9 | 3.4 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.9 | 2.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.9 | 2.6 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.9 | 0.9 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.8 | 3.3 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.8 | 4.1 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.8 | 0.8 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.8 | 2.4 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.8 | 6.5 | GO:0033572 | transferrin transport(GO:0033572) |
0.8 | 2.4 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.8 | 1.6 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.8 | 1.6 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.8 | 1.6 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.8 | 15.7 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.8 | 1.6 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.8 | 1.5 | GO:0034214 | protein hexamerization(GO:0034214) |
0.8 | 6.9 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.8 | 0.8 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.8 | 1.5 | GO:0051918 | regulation of fibrinolysis(GO:0051917) negative regulation of fibrinolysis(GO:0051918) |
0.8 | 2.3 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.8 | 2.3 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.8 | 1.5 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.7 | 3.7 | GO:1904970 | brush border assembly(GO:1904970) |
0.7 | 3.7 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.7 | 1.5 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.7 | 7.3 | GO:0015816 | glycine transport(GO:0015816) |
0.7 | 5.8 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.7 | 1.5 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.7 | 2.2 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.7 | 7.9 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.7 | 2.1 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.7 | 0.7 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.7 | 4.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.7 | 2.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.7 | 2.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.7 | 2.1 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.7 | 2.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.7 | 2.7 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.7 | 1.4 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.7 | 2.0 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.7 | 4.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.7 | 2.0 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.7 | 1.4 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.7 | 1.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.7 | 2.0 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.7 | 2.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.7 | 2.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.7 | 4.6 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.7 | 2.0 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.7 | 3.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.7 | 1.3 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.7 | 5.3 | GO:0032329 | serine transport(GO:0032329) |
0.7 | 2.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.7 | 10.5 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.7 | 0.7 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.6 | 1.3 | GO:0031033 | myosin filament organization(GO:0031033) |
0.6 | 3.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.6 | 0.6 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.6 | 3.1 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.6 | 2.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.6 | 1.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.6 | 1.2 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.6 | 1.9 | GO:0016237 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.6 | 0.6 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.6 | 1.8 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.6 | 3.6 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.6 | 2.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.6 | 4.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.6 | 0.6 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.6 | 3.0 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.6 | 3.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.6 | 2.4 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.6 | 0.6 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.6 | 0.6 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.6 | 1.2 | GO:0035425 | autocrine signaling(GO:0035425) |
0.6 | 0.6 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.6 | 6.4 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.6 | 1.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.6 | 1.7 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.6 | 4.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.6 | 1.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.6 | 2.3 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.6 | 1.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.6 | 2.2 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.6 | 1.1 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.5 | 1.1 | GO:0002254 | kinin cascade(GO:0002254) |
0.5 | 3.3 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.5 | 2.7 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.5 | 1.1 | GO:0060435 | bronchiole development(GO:0060435) |
0.5 | 2.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.5 | 7.6 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.5 | 0.5 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.5 | 4.8 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.5 | 2.7 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.5 | 2.7 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.5 | 5.8 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.5 | 1.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.5 | 1.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.5 | 1.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.5 | 4.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.5 | 1.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.5 | 1.6 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.5 | 2.1 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.5 | 0.5 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.5 | 1.0 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.5 | 1.5 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.5 | 1.5 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.5 | 1.0 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.5 | 2.5 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.5 | 2.0 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.5 | 1.5 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.5 | 2.5 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.5 | 1.5 | GO:0061010 | gall bladder development(GO:0061010) |
0.5 | 1.5 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.5 | 1.5 | GO:0098751 | bone cell development(GO:0098751) |
0.5 | 2.9 | GO:0015671 | oxygen transport(GO:0015671) |
0.5 | 1.5 | GO:0060058 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.5 | 1.4 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.5 | 0.9 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.5 | 1.4 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.5 | 0.9 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.5 | 0.9 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.5 | 1.9 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.5 | 6.0 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.5 | 2.3 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.5 | 5.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.5 | 3.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.5 | 6.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.5 | 2.3 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.5 | 1.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.5 | 1.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.5 | 1.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.5 | 0.5 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.5 | 1.4 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.4 | 2.2 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.4 | 3.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.4 | 1.3 | GO:0032439 | endosome localization(GO:0032439) |
0.4 | 0.4 | GO:0002215 | defense response to nematode(GO:0002215) |
0.4 | 3.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.4 | 1.3 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.4 | 0.4 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.4 | 0.9 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.4 | 0.4 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.4 | 2.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.4 | 1.3 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.4 | 1.3 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.4 | 3.0 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.4 | 0.4 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.4 | 0.4 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.4 | 1.7 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.4 | 4.6 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.4 | 3.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.4 | 1.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.4 | 1.2 | GO:0071047 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.4 | 3.2 | GO:0007343 | egg activation(GO:0007343) |
0.4 | 1.2 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.4 | 4.9 | GO:0051601 | exocyst localization(GO:0051601) |
0.4 | 0.4 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.4 | 1.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.4 | 2.0 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.4 | 3.2 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.4 | 1.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.4 | 1.6 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.4 | 3.2 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.4 | 0.4 | GO:0039534 | regulation of MDA-5 signaling pathway(GO:0039533) negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.4 | 4.0 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.4 | 0.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.4 | 1.2 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.4 | 2.8 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.4 | 4.0 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.4 | 1.6 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.4 | 1.6 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.4 | 2.0 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.4 | 1.6 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.4 | 1.2 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.4 | 1.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.4 | 6.6 | GO:0034340 | response to type I interferon(GO:0034340) |
0.4 | 1.9 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.4 | 1.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.4 | 0.4 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) positive regulation of receptor catabolic process(GO:2000646) |
0.4 | 3.9 | GO:0019081 | viral translation(GO:0019081) |
0.4 | 1.9 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.4 | 1.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.4 | 1.5 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.4 | 0.8 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.4 | 2.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.4 | 1.9 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.4 | 0.8 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.4 | 1.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.4 | 0.7 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.4 | 0.7 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.4 | 1.1 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.4 | 1.1 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.4 | 2.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.4 | 3.0 | GO:0051014 | actin filament severing(GO:0051014) |
0.4 | 0.7 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.4 | 7.7 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.4 | 1.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 0.4 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.4 | 0.4 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.4 | 0.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.4 | 0.4 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.4 | 1.4 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.4 | 1.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.4 | 0.4 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.4 | 0.4 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.4 | 2.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.4 | 0.4 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.4 | 0.7 | GO:0070268 | cornification(GO:0070268) |
0.4 | 1.8 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.4 | 0.4 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.4 | 1.1 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) |
0.3 | 0.3 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.3 | 3.4 | GO:0019985 | translesion synthesis(GO:0019985) |
0.3 | 0.7 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.3 | 1.4 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.3 | 0.3 | GO:1903972 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.3 | 2.0 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.3 | 1.0 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.3 | 4.4 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.3 | 1.7 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.3 | 0.3 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.3 | 2.7 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.3 | 2.7 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.3 | 0.3 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.3 | 2.7 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.3 | 0.7 | GO:0042117 | monocyte activation(GO:0042117) |
0.3 | 4.7 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.3 | 0.3 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.3 | 0.3 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.3 | 1.0 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.3 | 0.7 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.3 | 1.3 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.3 | 1.0 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.3 | 1.0 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.3 | 1.3 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.3 | 0.6 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.3 | 1.0 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.3 | 1.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.3 | 1.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.3 | 1.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.3 | 0.3 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.3 | 0.9 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 0.9 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.3 | 1.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.3 | 0.6 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.3 | 2.2 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.3 | 0.3 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.3 | 0.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.3 | 0.6 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.3 | 1.5 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.3 | 5.2 | GO:0017144 | drug metabolic process(GO:0017144) |
0.3 | 1.2 | GO:1901563 | response to camptothecin(GO:1901563) |
0.3 | 0.9 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.3 | 0.3 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.3 | 3.3 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.3 | 1.2 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.3 | 0.6 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.3 | 1.8 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.3 | 0.6 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.3 | 1.8 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.3 | 0.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 3.5 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.3 | 1.2 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.3 | 1.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 0.9 | GO:0015886 | heme transport(GO:0015886) |
0.3 | 0.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.3 | 3.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.3 | 0.3 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.3 | 0.6 | GO:0070459 | prolactin secretion(GO:0070459) |
0.3 | 1.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.3 | 5.1 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.3 | 6.3 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.3 | 0.6 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.3 | 0.3 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.3 | 0.6 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.3 | 0.6 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.3 | 0.6 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.3 | 2.3 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.3 | 0.3 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.3 | 0.3 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.3 | 2.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 6.5 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.3 | 1.7 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.3 | 0.8 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 2.0 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.3 | 0.3 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.3 | 3.4 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.3 | 0.6 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.3 | 0.8 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.3 | 2.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.3 | 0.3 | GO:0070777 | D-amino acid transport(GO:0042940) D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.3 | 0.3 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
0.3 | 2.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.3 | 5.8 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.3 | 5.5 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.3 | 2.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 0.5 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.3 | 4.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 0.8 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.3 | 1.1 | GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043372) |
0.3 | 1.9 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.3 | 1.6 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.3 | 0.5 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.3 | 1.6 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.3 | 2.2 | GO:0050702 | interleukin-1 beta secretion(GO:0050702) |
0.3 | 0.5 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.3 | 1.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.3 | 2.7 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.3 | 2.4 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.3 | 1.6 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.3 | 1.3 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.3 | 0.5 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 0.3 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.3 | 0.3 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.3 | 0.8 | GO:0033762 | response to glucagon(GO:0033762) |
0.3 | 0.8 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.3 | 1.3 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.3 | 1.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 2.9 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.3 | 2.6 | GO:0002931 | response to ischemia(GO:0002931) |
0.3 | 4.4 | GO:0048821 | erythrocyte development(GO:0048821) |
0.3 | 1.5 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.3 | 0.5 | GO:0060416 | response to growth hormone(GO:0060416) |
0.3 | 1.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.3 | 1.0 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.3 | 1.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 1.5 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.3 | 1.8 | GO:0051026 | chiasma assembly(GO:0051026) |
0.3 | 2.8 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.3 | 0.3 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
0.3 | 1.0 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
0.3 | 1.3 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.3 | 0.3 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) fungiform papilla formation(GO:0061198) |
0.2 | 0.7 | GO:0070345 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 5.7 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 1.2 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.2 | 0.5 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.2 | 1.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 2.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.2 | 2.0 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 1.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 3.9 | GO:0042832 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
0.2 | 0.7 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.2 | 1.0 | GO:1904705 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.2 | 1.5 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 0.5 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.2 | 1.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 1.2 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 1.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 0.5 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.2 | 2.2 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 2.2 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 1.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 2.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 1.4 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 1.7 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.2 | 0.7 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.2 | 0.2 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.2 | 0.9 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 0.5 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 1.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 1.4 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 2.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.5 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 0.5 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.2 | 0.2 | GO:0044838 | cell quiescence(GO:0044838) |
0.2 | 0.7 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 0.2 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
0.2 | 1.4 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 0.5 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 1.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 1.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.9 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 1.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 7.6 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.2 | 0.2 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.2 | 0.2 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.2 | 0.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.7 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 0.5 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.2 | 1.8 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 0.5 | GO:0006848 | pyruvate transport(GO:0006848) |
0.2 | 0.9 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.7 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.2 | 1.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 1.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 2.7 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.2 | 0.2 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.2 | 0.7 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.2 | 0.2 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 0.2 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.2 | 0.4 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.2 | 0.2 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.2 | 0.9 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.2 | 0.2 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.9 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 0.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 0.9 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.2 | 1.5 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) |
0.2 | 1.3 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.2 | 0.4 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 0.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.2 | 1.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 0.4 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.2 | 0.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 0.6 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.2 | 0.4 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.2 | 0.2 | GO:2000104 | negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.2 | 0.6 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.2 | 0.4 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.2 | 2.6 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.2 | 1.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 1.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.2 | GO:1902075 | cellular response to salt(GO:1902075) |
0.2 | 1.3 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.2 | 0.4 | GO:0010872 | regulation of cholesterol esterification(GO:0010872) |
0.2 | 1.5 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 2.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 3.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 1.4 | GO:0007097 | nuclear migration(GO:0007097) |
0.2 | 1.0 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.2 | 0.8 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 1.2 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.2 | 0.4 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 0.6 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.2 | 0.8 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.2 | 0.4 | GO:1903299 | regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
0.2 | 0.4 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.2 | 16.1 | GO:0030183 | B cell differentiation(GO:0030183) |
0.2 | 2.0 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 1.0 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.2 | 0.8 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.2 | 0.6 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) |
0.2 | 0.6 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.2 | 0.4 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.2 | 0.6 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 1.0 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.2 | 0.6 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 1.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 1.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.6 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.2 | 0.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 1.0 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 1.6 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 1.0 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 3.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 0.8 | GO:0009299 | mRNA transcription(GO:0009299) |
0.2 | 0.6 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.2 | 1.0 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.2 | 0.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 0.2 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.2 | 1.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.2 | 0.4 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 0.4 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.2 | 0.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 0.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 1.1 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.2 | 0.6 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.2 | 0.4 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.2 | 0.2 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.2 | 1.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 0.6 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 5.9 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.2 | 0.4 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.2 | 0.9 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 0.6 | GO:0009223 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.2 | 0.4 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.2 | 0.6 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.2 | 0.4 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.2 | 2.8 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 2.0 | GO:0072678 | T cell migration(GO:0072678) |
0.2 | 2.0 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.2 | 1.7 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.2 | 2.8 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 0.2 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.2 | 1.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 1.1 | GO:0010226 | response to lithium ion(GO:0010226) |
0.2 | 0.4 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.2 | 0.7 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.2 | 1.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 0.7 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 0.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.2 | 0.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 0.5 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.2 | 0.2 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.2 | 0.2 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.2 | 0.7 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.2 | 0.2 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.2 | 2.3 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.2 | 1.9 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 1.4 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 1.1 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.2 | 0.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.2 | 0.4 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 0.5 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 0.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 0.2 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.2 | 0.9 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.2 | 0.3 | GO:0002586 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.2 | 0.7 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.2 | 0.2 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.2 | 6.0 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 1.2 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) |
0.2 | 0.5 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.2 | 1.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.2 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 0.7 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 0.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 0.7 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 0.2 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.2 | 0.3 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.2 | 0.5 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 0.8 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.2 | 1.0 | GO:0086073 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.2 | 0.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.2 | 0.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 0.3 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.2 | 0.7 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 0.7 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.2 | 0.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 0.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.2 | 0.5 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.2 | 1.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 0.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 1.5 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 0.5 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 2.2 | GO:0051904 | pigment granule transport(GO:0051904) |
0.2 | 0.2 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.2 | 5.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 0.5 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 0.5 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 0.2 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.2 | 1.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.2 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.2 | 1.1 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 0.2 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.2 | 1.8 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.2 | 0.5 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.2 | 2.3 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.2 | 1.8 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 0.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 0.3 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.2 | 0.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 3.5 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.2 | 0.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.3 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.2 | 0.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 2.7 | GO:0032642 | regulation of chemokine production(GO:0032642) |
0.2 | 7.4 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.2 | 0.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.6 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.2 | 0.3 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.2 | 0.8 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 0.8 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 0.3 | GO:0060268 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
0.2 | 0.8 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.2 | 0.5 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.2 | 0.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 0.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 1.6 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 1.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 0.8 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 1.7 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.2 | 2.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 1.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.5 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.2 | 0.3 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.2 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 0.3 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 1.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.2 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.2 | 0.5 | GO:0014889 | muscle atrophy(GO:0014889) |
0.2 | 0.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.2 | 0.2 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.2 | 0.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.2 | 0.2 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.2 | 1.4 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 0.3 | GO:0030421 | defecation(GO:0030421) |
0.2 | 0.5 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 0.2 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.2 | 0.8 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.2 | 0.3 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.2 | 0.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.9 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 0.1 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.1 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.4 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.3 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.6 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
0.1 | 0.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 1.0 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 0.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 1.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 4.1 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.1 | 1.3 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.4 | GO:2000192 | negative regulation of icosanoid secretion(GO:0032304) negative regulation of fatty acid transport(GO:2000192) |
0.1 | 6.0 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 1.3 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 3.9 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.1 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.1 | 0.6 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.1 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.1 | 1.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.9 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.1 | 1.6 | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
0.1 | 0.6 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 1.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 1.7 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 1.0 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.1 | 1.7 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.7 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) |
0.1 | 1.0 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.8 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 1.0 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.1 | 0.4 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.1 | 1.1 | GO:0097286 | iron ion import(GO:0097286) |
0.1 | 0.6 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 1.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.6 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 1.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 5.1 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 1.0 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 0.8 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 0.1 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.1 | 0.3 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.1 | 0.4 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.1 | GO:0071724 | response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.1 | 0.1 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.1 | 1.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 1.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 2.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.1 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.1 | 0.3 | GO:0042148 | strand invasion(GO:0042148) |
0.1 | 0.1 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.1 | 0.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.7 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.8 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 2.5 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 0.9 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.4 | GO:0090322 | negative regulation of superoxide anion generation(GO:0032929) regulation of superoxide metabolic process(GO:0090322) |
0.1 | 0.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 1.8 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 1.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.1 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.9 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.4 | GO:2000816 | negative regulation of mitotic metaphase/anaphase transition(GO:0045841) mitotic spindle checkpoint(GO:0071174) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) negative regulation of mitotic sister chromatid separation(GO:2000816) |
0.1 | 0.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.1 | 0.4 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.1 | 0.3 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.8 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 1.0 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.1 | 0.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.5 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.8 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 1.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.4 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.1 | 1.4 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 0.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.1 | 0.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 1.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.5 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.6 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.4 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 0.4 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
0.1 | 0.2 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.1 | 0.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 2.9 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 2.0 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.1 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.1 | 2.1 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 1.3 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.5 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.1 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.1 | 0.2 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.9 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.1 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
0.1 | 1.0 | GO:0051168 | nuclear export(GO:0051168) |
0.1 | 0.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.8 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.1 | 0.1 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.1 | 0.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.3 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.1 | 0.5 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.1 | 0.3 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.2 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.2 | GO:0050701 | interleukin-1 secretion(GO:0050701) |
0.1 | 0.3 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.1 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.1 | 0.5 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.1 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.1 | 1.2 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 1.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.3 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.2 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.3 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 0.2 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.3 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 0.8 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.5 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 6.3 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.5 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 3.1 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 0.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.3 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 1.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 1.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.1 | 1.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.2 | GO:0006498 | N-terminal protein lipidation(GO:0006498) N-terminal protein myristoylation(GO:0006499) |
0.1 | 0.6 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 1.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.7 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.4 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 1.1 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 1.4 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.1 | 0.3 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.2 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 0.5 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.1 | 0.4 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.1 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.1 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.6 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.3 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.2 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.1 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.2 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.1 | 1.8 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.5 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.1 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.1 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 0.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 1.6 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.6 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 0.1 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.1 | 0.8 | GO:0042255 | ribosome assembly(GO:0042255) |
0.1 | 0.9 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.1 | 3.7 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 1.2 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.1 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.5 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 3.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 1.0 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 3.2 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 1.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.7 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 1.1 | GO:0035307 | positive regulation of protein dephosphorylation(GO:0035307) |
0.1 | 0.3 | GO:0033750 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.1 | 0.1 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.1 | 0.4 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.2 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.1 | 0.9 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.5 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.1 | 0.1 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 1.6 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.1 | 0.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.2 | GO:0009838 | abscission(GO:0009838) |
0.1 | 2.2 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.4 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 0.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 1.0 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.1 | 2.2 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.1 | 0.6 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.2 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.1 | 0.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.4 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 2.3 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.1 | 0.5 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.1 | 0.3 | GO:1904385 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.1 | 0.3 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.1 | 0.1 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.2 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.1 | 0.3 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.3 | GO:1903573 | negative regulation of response to endoplasmic reticulum stress(GO:1903573) |
0.1 | 0.2 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.1 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.1 | 0.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.2 | GO:0071305 | cellular response to vitamin D(GO:0071305) |
0.1 | 0.2 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.7 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 1.1 | GO:0048525 | negative regulation of viral process(GO:0048525) |
0.1 | 0.3 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.3 | GO:0019068 | virion assembly(GO:0019068) |
0.1 | 0.2 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.2 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.1 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.6 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 0.3 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.1 | 0.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.2 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.2 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.2 | GO:0061515 | myeloid cell development(GO:0061515) |
0.1 | 0.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.4 | GO:0042026 | protein refolding(GO:0042026) |
0.1 | 0.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.2 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.7 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.3 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 1.9 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 1.0 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 0.2 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 1.9 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 0.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.1 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 0.2 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.5 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.2 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.1 | GO:0072109 | glomerular mesangium development(GO:0072109) |
0.1 | 0.3 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.4 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.3 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.1 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.1 | 0.3 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 0.1 | GO:0033079 | immature T cell proliferation(GO:0033079) |
0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 0.4 | GO:0038066 | p38MAPK cascade(GO:0038066) |
0.1 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 3.3 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 0.8 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.1 | 0.5 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.1 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 0.8 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.1 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.1 | 0.4 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.6 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.1 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.1 | 0.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.1 | GO:0033280 | response to vitamin D(GO:0033280) |
0.1 | 0.1 | GO:0051352 | negative regulation of ligase activity(GO:0051352) |
0.1 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.4 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.1 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.1 | 0.5 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.5 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.6 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.3 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.2 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 0.8 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 0.1 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.1 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.1 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 0.2 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.5 | GO:0048599 | oocyte development(GO:0048599) |
0.1 | 0.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.1 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.1 | 1.2 | GO:0060323 | head morphogenesis(GO:0060323) |
0.1 | 0.1 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.1 | GO:0060751 | branch elongation involved in mammary gland duct branching(GO:0060751) |
0.1 | 0.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.1 | 0.2 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.2 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.1 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 1.8 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.1 | 0.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.2 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.1 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.1 | GO:0060713 | labyrinthine layer morphogenesis(GO:0060713) |
0.1 | 0.1 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.1 | GO:0010677 | negative regulation of cellular carbohydrate metabolic process(GO:0010677) |
0.1 | 0.1 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.1 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.4 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.2 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 0.1 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.1 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.3 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.2 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.1 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.2 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.1 | 0.1 | GO:1901301 | cargo loading into vesicle(GO:0035459) regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.2 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.2 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 0.4 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.1 | GO:0000237 | leptotene(GO:0000237) |
0.1 | 0.2 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.1 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.1 | 0.1 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
0.1 | 0.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 1.5 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.1 | GO:0032344 | regulation of aldosterone metabolic process(GO:0032344) |
0.1 | 0.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.1 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.2 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.1 | 0.2 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.6 | GO:0035690 | cellular response to drug(GO:0035690) |
0.1 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 1.0 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.1 | GO:0046655 | folic acid metabolic process(GO:0046655) pharyngeal arch artery morphogenesis(GO:0061626) |
0.1 | 0.3 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.1 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.1 | 0.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.1 | 0.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.1 | 1.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.1 | GO:0072239 | metanephric glomerulus vasculature development(GO:0072239) |
0.1 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.1 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.1 | 0.1 | GO:0072224 | metanephric glomerulus development(GO:0072224) |
0.1 | 0.5 | GO:0007143 | female meiotic division(GO:0007143) |
0.1 | 0.7 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.1 | GO:0030952 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 0.1 | GO:0007418 | ventral midline development(GO:0007418) floor plate morphogenesis(GO:0033505) |
0.1 | 0.1 | GO:0006900 | membrane budding(GO:0006900) |
0.1 | 0.2 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 0.4 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.0 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.0 | 0.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.0 | GO:0034204 | lipid translocation(GO:0034204) |
0.0 | 0.1 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.0 | 0.5 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.0 | GO:0060426 | lung vasculature development(GO:0060426) |
0.0 | 0.0 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.0 | 0.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.2 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 1.9 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 0.7 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.6 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.0 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.2 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.1 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.0 | 0.2 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.0 | 0.0 | GO:0007619 | courtship behavior(GO:0007619) |
0.0 | 0.1 | GO:0033233 | regulation of protein sumoylation(GO:0033233) negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.4 | GO:0043489 | RNA stabilization(GO:0043489) |
0.0 | 0.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 2.0 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.0 | 0.7 | GO:0016575 | histone deacetylation(GO:0016575) |
0.0 | 0.0 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 2.2 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.1 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.0 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.0 | 0.1 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.0 | 0.0 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.0 | 0.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 2.4 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 0.4 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.0 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 0.0 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
0.0 | 0.1 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.0 | 0.6 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.0 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.1 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.0 | 0.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.0 | GO:0045912 | negative regulation of carbohydrate metabolic process(GO:0045912) |
0.0 | 0.1 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.0 | 0.1 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.0 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.0 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.0 | 0.0 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.0 | 0.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.1 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.0 | 0.0 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.0 | 1.3 | GO:0006818 | hydrogen transport(GO:0006818) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.4 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.7 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.0 | GO:0009301 | snRNA transcription(GO:0009301) |
0.0 | 0.1 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.0 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.0 | 0.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 | 0.1 | GO:0046112 | nucleobase biosynthetic process(GO:0046112) |
0.0 | 2.6 | GO:0051321 | meiotic cell cycle(GO:0051321) |
0.0 | 0.1 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.0 | 3.8 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.0 | GO:0015669 | gas transport(GO:0015669) |
0.0 | 0.0 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.0 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.2 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.1 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.0 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.4 | GO:0043627 | response to estrogen(GO:0043627) |
0.0 | 0.5 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.0 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.0 | 0.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.2 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.0 | 0.5 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.0 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
0.0 | 0.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.1 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.0 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.0 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.3 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.1 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.0 | 0.0 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.0 | 0.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.0 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.0 | 0.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.0 | 0.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.0 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.0 | 0.0 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.0 | 0.0 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.0 | 0.2 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.0 | 0.1 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.0 | 0.7 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.3 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.0 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.0 | 0.0 | GO:0060482 | lobar bronchus development(GO:0060482) |
0.0 | 0.0 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.3 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.0 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.0 | 0.3 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.0 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.1 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.0 | 0.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.0 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.0 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.0 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.0 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.0 | 0.1 | GO:0072529 | pyrimidine-containing compound catabolic process(GO:0072529) |
0.0 | 0.1 | GO:0051341 | regulation of oxidoreductase activity(GO:0051341) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.0 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.0 | 0.0 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.0 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.0 | 0.0 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.0 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.0 | 0.1 | GO:0034311 | diol metabolic process(GO:0034311) |
0.0 | 0.0 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.0 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.0 | 0.1 | GO:1901031 | regulation of response to reactive oxygen species(GO:1901031) |
0.0 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.0 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.0 | GO:0035928 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
0.0 | 0.0 | GO:0009414 | response to water deprivation(GO:0009414) |
0.0 | 0.0 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
0.0 | 0.0 | GO:1902093 | regulation of sperm motility(GO:1901317) positive regulation of sperm motility(GO:1902093) |
0.0 | 0.0 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.0 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.0 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 0.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.0 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.0 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
0.0 | 0.0 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.0 | 0.0 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.0 | 0.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.0 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.0 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) primary lung bud formation(GO:0060431) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.0 | 0.0 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.0 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.0 | 0.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.0 | 0.0 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 1.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.0 | 0.0 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.0 | 0.0 | GO:2000662 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
0.0 | 0.0 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.0 | GO:0071025 | RNA surveillance(GO:0071025) |
0.0 | 0.0 | GO:0032647 | regulation of interferon-alpha production(GO:0032647) |
0.0 | 0.0 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.0 | 0.0 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.0 | 0.0 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.0 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.0 | 0.0 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.0 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.0 | 0.0 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.0 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 22.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
2.2 | 8.9 | GO:0019815 | B cell receptor complex(GO:0019815) |
2.2 | 6.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.4 | 7.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.2 | 3.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.2 | 3.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
1.2 | 8.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.2 | 7.1 | GO:0031983 | vesicle lumen(GO:0031983) |
1.1 | 5.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.0 | 4.1 | GO:1990246 | uniplex complex(GO:1990246) |
1.0 | 6.1 | GO:1990462 | omegasome(GO:1990462) |
1.0 | 2.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.9 | 3.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.9 | 3.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.9 | 27.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.8 | 3.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.8 | 5.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.8 | 6.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.8 | 3.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.8 | 4.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.8 | 4.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.8 | 5.5 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.8 | 7.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.8 | 5.4 | GO:0090543 | Flemming body(GO:0090543) |
0.8 | 3.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.7 | 8.2 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.7 | 2.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.7 | 3.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.7 | 3.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.7 | 2.0 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.7 | 2.0 | GO:0005642 | annulate lamellae(GO:0005642) |
0.7 | 2.6 | GO:0042583 | chromaffin granule(GO:0042583) |
0.6 | 1.9 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.6 | 0.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) cation-transporting ATPase complex(GO:0090533) |
0.6 | 3.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.6 | 4.0 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.6 | 2.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.5 | 1.6 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.5 | 4.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.5 | 3.2 | GO:0070938 | contractile ring(GO:0070938) |
0.5 | 2.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.5 | 1.5 | GO:0070820 | tertiary granule(GO:0070820) |
0.5 | 4.5 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.5 | 1.5 | GO:0070552 | BRISC complex(GO:0070552) |
0.5 | 2.0 | GO:0000322 | storage vacuole(GO:0000322) |
0.5 | 2.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.5 | 2.8 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 1.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.5 | 2.3 | GO:0000805 | X chromosome(GO:0000805) |
0.5 | 3.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.5 | 2.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.4 | 0.9 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.4 | 1.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.4 | 1.3 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.4 | 1.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.4 | 2.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.4 | 1.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 2.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.4 | 2.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.4 | 3.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.4 | 1.5 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.4 | 5.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.4 | 1.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.4 | 6.0 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 0.7 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.4 | 1.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.4 | 1.4 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.4 | 1.1 | GO:0071203 | WASH complex(GO:0071203) |
0.4 | 0.4 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 2.8 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.3 | 1.4 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 1.0 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.3 | 2.0 | GO:0032009 | early phagosome(GO:0032009) |
0.3 | 8.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 1.0 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.3 | 1.7 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 0.7 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 1.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.3 | 4.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 1.6 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 0.7 | GO:0033646 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.3 | 10.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 2.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.3 | 0.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 2.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 0.9 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.3 | 0.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.3 | 2.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 0.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 4.5 | GO:0031430 | M band(GO:0031430) |
0.3 | 2.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.3 | 0.6 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 1.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.3 | 1.5 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.3 | 0.3 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.3 | 3.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 2.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 0.3 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.3 | 2.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 0.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.3 | 0.8 | GO:0089701 | U2AF(GO:0089701) |
0.3 | 2.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 0.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 0.8 | GO:0035838 | growing cell tip(GO:0035838) |
0.3 | 2.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 0.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.3 | 0.5 | GO:0097342 | ripoptosome(GO:0097342) |
0.3 | 2.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 0.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 1.5 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 1.5 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 2.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 1.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 1.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 2.4 | GO:0032797 | SMN complex(GO:0032797) |
0.2 | 0.7 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 0.5 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 1.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 2.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 1.9 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 0.7 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.2 | 0.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 2.6 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 13.9 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 0.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.2 | 0.9 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 0.9 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 0.7 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.2 | 2.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 0.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.2 | 4.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 2.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 0.2 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 0.8 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 2.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 4.4 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 14.5 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 0.8 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 0.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 0.8 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.2 | 1.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 1.2 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 0.6 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 0.8 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 11.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 2.0 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 2.7 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 4.3 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 1.2 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 1.0 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 0.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 0.9 | GO:0001739 | sex chromatin(GO:0001739) |
0.2 | 0.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 0.4 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.2 | 0.7 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 1.8 | GO:0008278 | cohesin complex(GO:0008278) |
0.2 | 0.7 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 1.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 0.5 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.2 | 0.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 0.7 | GO:0032021 | NELF complex(GO:0032021) |
0.2 | 0.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 0.7 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.2 | 0.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 1.0 | GO:0070847 | core mediator complex(GO:0070847) |
0.2 | 14.3 | GO:0005938 | cell cortex(GO:0005938) |
0.2 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 1.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 1.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 6.8 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.2 | 0.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 10.3 | GO:0016605 | PML body(GO:0016605) |
0.2 | 1.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 1.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 0.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 3.8 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 0.8 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.2 | 1.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 1.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 0.6 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 0.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 0.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 1.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 0.5 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 1.3 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 8.4 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.5 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 2.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 2.2 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 0.6 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.2 | 4.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 0.6 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.2 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 0.6 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 0.6 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 8.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 12.2 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.9 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 1.9 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 1.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 3.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 3.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 2.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 1.4 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 5.8 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.1 | 0.7 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 1.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 16.7 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.4 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 6.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.9 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 9.3 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 1.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.8 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 10.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 1.0 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 1.0 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 1.0 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 0.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 1.0 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 29.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 3.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 2.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.2 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 0.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.2 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 2.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.5 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.1 | 0.3 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.4 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 1.8 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.3 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.1 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 2.5 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.8 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 1.0 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.6 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.4 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 1.2 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.7 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 2.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 3.4 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.3 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 6.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.2 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.2 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.1 | 1.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.8 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 1.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 9.9 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 1.1 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 0.5 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 86.0 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.3 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.1 | GO:0005818 | aster(GO:0005818) |
0.1 | 2.1 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.3 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 4.2 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 1.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 4.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.2 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 1.4 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 115.6 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.6 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.1 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 0.2 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 1.7 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.5 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 2.5 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 1.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 1.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.7 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 4.0 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 0.5 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.1 | 0.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.5 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.2 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 0.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.4 | GO:0000803 | sex chromosome(GO:0000803) |
0.1 | 0.5 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.4 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 1.1 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 0.5 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 0.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 1.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 1.2 | GO:0016604 | nuclear body(GO:0016604) |
0.0 | 0.4 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.0 | 0.1 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.0 | 0.9 | GO:0000793 | condensed chromosome(GO:0000793) |
0.0 | 0.3 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 1.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 5.9 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.0 | GO:1990696 | USH2 complex(GO:1990696) |
0.0 | 0.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.0 | 0.2 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.0 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 30.1 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.3 | GO:0000786 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.0 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.9 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.0 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.0 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.0 | 0.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.0 | 0.0 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.0 | 0.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.0 | 1.1 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.2 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 13.1 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 2.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 4.2 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.0 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 0.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.0 | 0.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.0 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 0.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 14.8 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.1 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.0 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 1.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.1 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.0 | 0.0 | GO:0070187 | telosome(GO:0070187) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 24.3 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
2.6 | 7.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
2.1 | 8.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
2.0 | 14.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
1.9 | 7.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.6 | 4.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.5 | 4.6 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
1.5 | 6.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.5 | 4.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.4 | 4.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.4 | 4.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.3 | 4.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.3 | 3.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.3 | 6.3 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
1.2 | 4.8 | GO:0051425 | PTB domain binding(GO:0051425) |
1.1 | 3.4 | GO:0035877 | death effector domain binding(GO:0035877) |
1.1 | 3.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.1 | 3.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.1 | 5.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
1.1 | 4.3 | GO:0009374 | biotin binding(GO:0009374) |
1.0 | 6.2 | GO:0004064 | arylesterase activity(GO:0004064) |
1.0 | 3.1 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.0 | 7.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.0 | 7.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
1.0 | 2.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
1.0 | 4.0 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
1.0 | 3.9 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.0 | 8.8 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.0 | 2.9 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.9 | 2.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.9 | 6.5 | GO:0019864 | IgG binding(GO:0019864) |
0.9 | 5.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.9 | 2.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.9 | 3.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.9 | 6.8 | GO:1990405 | protein antigen binding(GO:1990405) |
0.8 | 5.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.8 | 2.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.8 | 3.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.8 | 2.5 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.8 | 3.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.8 | 7.4 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.8 | 4.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.8 | 2.5 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.8 | 5.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.8 | 5.7 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.8 | 8.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.8 | 2.4 | GO:0019862 | IgA binding(GO:0019862) |
0.8 | 4.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.8 | 3.9 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.8 | 6.8 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.8 | 6.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.8 | 2.3 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.8 | 2.3 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.7 | 2.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.7 | 2.9 | GO:0030984 | kininogen binding(GO:0030984) |
0.7 | 2.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.7 | 2.8 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.7 | 2.1 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.7 | 6.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.7 | 2.7 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.7 | 4.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.7 | 1.4 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.7 | 2.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.7 | 3.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.7 | 3.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.6 | 3.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.6 | 1.9 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.6 | 2.5 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.6 | 1.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.6 | 1.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.6 | 0.6 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.6 | 1.8 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.6 | 17.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.6 | 5.3 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.6 | 1.8 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.6 | 1.8 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.6 | 5.9 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.6 | 1.7 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.6 | 1.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.6 | 9.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.6 | 4.5 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.6 | 0.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.6 | 3.9 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.6 | 1.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.5 | 10.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.5 | 6.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.5 | 3.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.5 | 1.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.5 | 2.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.5 | 1.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.5 | 2.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.5 | 1.0 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.5 | 1.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.5 | 2.0 | GO:0030911 | TPR domain binding(GO:0030911) |
0.5 | 1.5 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.5 | 1.0 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.5 | 2.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.5 | 1.4 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.5 | 1.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.5 | 1.9 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.5 | 4.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.5 | 2.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.5 | 1.9 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.5 | 3.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.5 | 4.6 | GO:0004568 | chitinase activity(GO:0004568) |
0.5 | 2.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.5 | 2.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.5 | 3.6 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.5 | 1.8 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.5 | 8.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.4 | 1.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.4 | 1.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.4 | 0.4 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.4 | 4.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.4 | 0.4 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.4 | 2.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.4 | 1.3 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.4 | 2.6 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.4 | 3.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 2.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.4 | 2.5 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.4 | 4.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.4 | 11.9 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.4 | 1.2 | GO:0016726 | aldehyde oxidase activity(GO:0004031) xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.4 | 1.6 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.4 | 2.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.4 | 1.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 2.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.4 | 3.2 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.4 | 1.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 0.4 | GO:0032190 | acrosin binding(GO:0032190) |
0.4 | 0.8 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.4 | 0.4 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.4 | 2.0 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.4 | 1.6 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 1.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.4 | 3.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.4 | 2.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 1.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.4 | 1.9 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.4 | 1.5 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.4 | 1.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.4 | 1.8 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.4 | 3.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.4 | 0.4 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 1.4 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 1.4 | GO:0042731 | PH domain binding(GO:0042731) |
0.3 | 3.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.3 | 1.7 | GO:0035197 | siRNA binding(GO:0035197) |
0.3 | 1.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 5.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 0.3 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.3 | 1.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 0.7 | GO:0036033 | mediator complex binding(GO:0036033) |
0.3 | 1.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 1.7 | GO:0070513 | death domain binding(GO:0070513) |
0.3 | 2.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.3 | 1.3 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.3 | 3.0 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.3 | 1.0 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.3 | 1.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 6.2 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.3 | 3.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 2.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 0.7 | GO:0008199 | ferric iron binding(GO:0008199) |
0.3 | 1.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.3 | 0.3 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.3 | 1.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.3 | 3.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.3 | 1.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 1.0 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.3 | 2.6 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.3 | 5.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 21.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.3 | 0.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.3 | 0.9 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.3 | 2.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 0.9 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.3 | 2.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 1.2 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 2.8 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.3 | 2.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 1.2 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 0.9 | GO:0016151 | nickel cation binding(GO:0016151) |
0.3 | 1.8 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.3 | 1.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 3.3 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 3.3 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 1.5 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 1.2 | GO:0043829 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.3 | 0.9 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.3 | 1.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.3 | 0.9 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.3 | 5.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 2.7 | GO:0016208 | AMP binding(GO:0016208) |
0.3 | 0.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 2.3 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.3 | 1.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.3 | 6.9 | GO:0032442 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.3 | 1.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 1.1 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.3 | 5.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 0.8 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.3 | 0.3 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.3 | 0.8 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.3 | 2.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.3 | 2.5 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.3 | 4.0 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.3 | 1.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.3 | 4.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.3 | 0.3 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.3 | 0.3 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.3 | 6.1 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.3 | 3.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 1.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 0.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 0.8 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 1.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 0.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 0.8 | GO:0016801 | adenosylhomocysteinase activity(GO:0004013) hydrolase activity, acting on ether bonds(GO:0016801) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 1.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 0.5 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.3 | 0.8 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.3 | 1.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.3 | 6.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.3 | 0.8 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 7.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.3 | 0.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 0.5 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.2 | 1.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 1.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 8.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 0.5 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.2 | 0.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 3.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 0.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 0.7 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 1.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 1.2 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 1.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 2.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 2.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.2 | 1.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 0.9 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.2 | 3.0 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 0.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 0.7 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 0.9 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 4.6 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 2.5 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.2 | 0.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 0.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 4.8 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.2 | 1.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 8.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 0.7 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 0.4 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 2.0 | GO:0034918 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 4.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 0.7 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.2 | 1.3 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.2 | 0.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 3.5 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 2.2 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 1.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 7.6 | GO:0004601 | peroxidase activity(GO:0004601) |
0.2 | 0.9 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 0.6 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.2 | 1.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 1.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.2 | 0.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.2 | 0.6 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.2 | 0.4 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.2 | 2.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 2.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 0.2 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.2 | 0.4 | GO:0019961 | interferon binding(GO:0019961) |
0.2 | 0.8 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 1.0 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.2 | 0.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.2 | 3.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 17.3 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 0.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 4.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.2 | 0.6 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 0.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 0.6 | GO:0004802 | transketolase activity(GO:0004802) |
0.2 | 1.0 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 2.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 1.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 1.8 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 1.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 3.7 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 2.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 0.8 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.6 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.2 | 1.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 1.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 1.9 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 0.8 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 1.7 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.2 | 0.8 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 2.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 1.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 2.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 0.9 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 0.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 1.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 1.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 1.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 3.5 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 1.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 0.7 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 0.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 0.9 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 0.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 0.7 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 2.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 12.5 | GO:0002020 | protease binding(GO:0002020) |
0.2 | 1.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 1.6 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 1.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 7.5 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.2 | 0.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 1.3 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.2 | 0.7 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 6.3 | GO:0019209 | kinase activator activity(GO:0019209) |
0.2 | 3.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 0.8 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 2.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 2.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 9.0 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.2 | 0.8 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 0.5 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 1.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 0.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 0.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 0.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 0.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 0.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 0.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 1.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 5.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.4 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 6.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 1.9 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 9.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 2.9 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 5.4 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 0.6 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 2.2 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 6.9 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 3.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.3 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.1 | 0.3 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.3 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 1.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.4 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 1.5 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 0.6 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 1.2 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.1 | 1.5 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.4 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 0.4 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.4 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 1.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.8 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 0.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.4 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 1.6 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 1.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.1 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 1.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 1.1 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.1 | 0.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 7.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.7 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 1.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.7 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 2.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 1.0 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 1.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.8 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.8 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.7 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.6 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.6 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.8 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.8 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.1 | 1.5 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 1.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 1.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.4 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 1.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 3.1 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.2 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 0.3 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 3.8 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.1 | 0.2 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.2 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 6.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.5 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 1.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 17.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 3.1 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 0.4 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.7 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 2.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 5.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 1.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.6 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 0.3 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.9 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 1.9 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.1 | 0.7 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 2.3 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 2.3 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 2.4 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.6 | GO:0043759 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 1.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.6 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 1.4 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 8.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 4.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 2.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 1.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.5 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 7.4 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.5 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 3.0 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 1.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 2.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.1 | 6.2 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 3.6 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 1.8 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 0.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 1.6 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.4 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 1.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.1 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.1 | 0.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 1.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 1.0 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 1.5 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 1.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 1.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 3.7 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.1 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.7 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 1.5 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 2.8 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 1.4 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 16.3 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.1 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 0.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.1 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.1 | 0.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.6 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 0.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.3 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.2 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.8 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 1.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 8.3 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 0.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 1.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 3.8 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.1 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.0 | 0.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.4 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.0 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 0.0 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.0 | 0.7 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 1.3 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.0 | 0.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.5 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.5 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.4 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.0 | 0.0 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.4 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 7.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 1.9 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.0 | 0.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.2 | GO:0016160 | amylase activity(GO:0016160) |
0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.1 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
0.0 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.2 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.1 | GO:0048019 | receptor inhibitor activity(GO:0030547) receptor antagonist activity(GO:0048019) |
0.0 | 1.0 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 2.4 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.2 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.0 | 0.1 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.0 | 0.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.0 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.0 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
0.0 | 0.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.4 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.0 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.1 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 0.0 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.0 | 0.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.0 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.0 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.0 | 0.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 1.5 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.2 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.0 | 0.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.4 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.0 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) nucleotide transmembrane transporter activity(GO:0015215) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 1.4 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
1.3 | 1.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.0 | 44.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.9 | 20.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.8 | 21.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.8 | 6.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.8 | 27.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.8 | 21.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.7 | 11.9 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.7 | 5.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.6 | 0.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.6 | 6.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.6 | 18.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.6 | 4.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.5 | 11.7 | PID MYC PATHWAY | C-MYC pathway |
0.5 | 19.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.5 | 21.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 15.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.5 | 8.4 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.4 | 6.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 3.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 4.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 4.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.4 | 5.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 3.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.4 | 2.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.4 | 12.6 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 2.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.3 | 13.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 7.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 7.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 4.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.3 | 7.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 8.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.3 | 6.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 7.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 28.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.3 | 5.0 | PID AURORA A PATHWAY | Aurora A signaling |
0.3 | 0.3 | ST STAT3 PATHWAY | STAT3 Pathway |
0.3 | 4.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 2.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 3.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 3.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 2.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 6.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 4.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 2.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 3.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 4.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 0.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 0.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 7.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 2.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 0.8 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 0.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 0.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 6.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 1.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 0.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 1.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 0.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 6.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 1.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 0.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 0.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 0.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 0.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 0.5 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 6.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 0.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 0.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 1.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 1.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 5.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 3.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.4 | PID ATM PATHWAY | ATM pathway |
0.1 | 5.1 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 1.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 1.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 1.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.7 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 1.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.4 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 1.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 0.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 1.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 1.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 11.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 1.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.8 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.4 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.0 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 13.8 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.6 | 15.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.3 | 1.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
1.3 | 16.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.2 | 12.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.0 | 14.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.9 | 9.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.8 | 10.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.8 | 21.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.7 | 6.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.7 | 7.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.7 | 2.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.7 | 18.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.7 | 26.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.7 | 5.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.7 | 14.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.6 | 17.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.6 | 3.4 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.6 | 1.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.5 | 12.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.5 | 10.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.5 | 12.7 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.5 | 5.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.5 | 4.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.5 | 6.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.5 | 8.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.5 | 16.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.5 | 4.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.5 | 4.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.5 | 0.5 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
0.5 | 4.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 1.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 4.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 4.9 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.4 | 6.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 3.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.4 | 5.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.4 | 4.9 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.4 | 6.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.4 | 10.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.4 | 6.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.4 | 4.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.4 | 7.9 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.4 | 2.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 2.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 18.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.3 | 4.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 3.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 3.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.3 | 1.6 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.3 | 2.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.3 | 3.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 0.9 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.3 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.3 | 1.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 1.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.3 | 2.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.3 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.3 | 3.9 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.3 | 4.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 2.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 1.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 2.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 3.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.3 | 3.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.2 | 3.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 2.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 6.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.2 | 2.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 8.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 3.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 2.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 6.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 5.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 15.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 1.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 3.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 7.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 0.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 5.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 5.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 0.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.2 | 0.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 2.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 1.8 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.2 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 0.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 1.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 1.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 2.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 2.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 2.6 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 2.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 2.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 0.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 3.0 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 1.4 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.2 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 0.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 0.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 2.9 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 1.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 1.2 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.2 | 2.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 1.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 1.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 2.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 1.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 0.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 1.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 1.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 2.9 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.9 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 3.1 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 3.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 0.3 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 0.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 8.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 2.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.9 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 1.7 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.1 | 0.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 5.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 2.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 0.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 10.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 0.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 2.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.7 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 0.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 0.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 0.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 1.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 2.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 2.7 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 1.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 5.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 4.0 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 2.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.1 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.1 | 0.7 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 3.2 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 2.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 0.5 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 7.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 1.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 3.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 0.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 1.2 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 0.2 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.1 | 5.4 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 1.1 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.9 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.1 | 1.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 1.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.6 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.0 | 1.5 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 0.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 1.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.6 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 0.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.3 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 1.3 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.0 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.1 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 0.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.0 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.0 | 0.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.0 | REACTOME CELL CYCLE MITOTIC | Genes involved in Cell Cycle, Mitotic |
0.0 | 0.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |